Abstract
The capacity of the specific narcotic antagonists naltrexone and naloxone to block the discriminative effects produced by morphine in the rat were evaluated using a two-choice, discrete-trial avoidance task. The antagonists produced a dose-dependent and time-dependent blockade of morphine's effects as measured by responding on the morphine-appropriate choice lever. Naltrexone and naloxone were equipotent when given subcutaneously concomitantly with subcutaneously administered morphine. However, when the antagonists were administered orally at 0, 2, 4 or 8 h prior to s.c. morphine, naltrexone was more potent that naloxone at every time point and had a duration of action at least twice that of oral naloxone. The discriminitive effects of the narcotic analgesics morphine and methadone were also compared after oral and subcutaneous administration. Both drugs produced dose-related discriminative effects and were one-tenth as potent by the oral as by the subcutaneous route of administration. These results suggest that the discriminative effects produced by morphine in the rat can provide an animal model for the quantitative evaluation of the narcotic antagonist properties of drugs that might be considered for use in narcotic antagonist maintenance programs for the treatment of narcotic addiction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blumberg, H., Dayton, H. B.: Naloxone and related compounds. In: Agonist and antagonist actions of narcotic analgesic drugs, H. W. Kosterlitz, H. O. J. Collier and J. E. Villarreal, eds., pp. 110–119. Baltimore: University Park Press 1973
Blumberg, H., Dayton, H. B.: Naloxone, naltrexone, and related noroxymorphones. In: Advances in biochemical psychopharmacology, vol. 8, M. C. Braude, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villarreal, eds., pp. 33–43, New York: Raven Press 1974
Fink, M., Zaks, A., Sharoff, R., Mora, A., Bruner, A., Levit S., Freedman, A. M.: Naloxone and heroin dependence. Clin. Pharmacol. Ther. 9, 568–577 (1968)
Gianutsos, G., Lal, H.: Effect of loperamide, haloperidol and methadone in rats trained to discriminate morphine from saline. Psychopharmacologia (Berl.) 41, 267–270 (1975)
Hays, W. L.: Statistics for the social sciences, 2nd ed. New York: Holt, Rinehart and Winston 1973
Holtzman, S. G.: Effects of morphine and narcotic antagonists on avoidance behavior of the squirrel monkey. J. Pharmacol. exp. Ther. 196, 145–155 (1976)
Houde, R. W., Wallenstein, S. L., Beaver, W. T.: Clinical measurements of pain. In: Analgesics, G. deStevens, ed., pp. 75–122. New York: Academic Press 1965
Jasinski, D. R., Martin, W. R., Haetzen, C. A.: The human pharmacology and abuse potential of N-allylnoroxymorphone (Naloxone). J. Pharmacol. exp. Ther. 157, 420–426 (1967)
Kosterlitz, H. W., Waterfield, A. A., Berthoud, V.: Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum. In: Advances in biochemical psychopharmacology, vol. 8, M. C. Braude, L. S. Harris, E. L. May, J. P. Smith, and J. I. Villarreal, eds. pp. 319–334. New York: Raven Press 1974
Martin, W. R.: Opioid antagonists. Pharmacol. Rev. 19, 463–521 (1967)
Martin, W. R., Eades, C. G., Thompson, W. O., Thompson, J. A., Flanary, H. G.: Morphine physical dependence in the dog. J. Pharmacol. exp. Ther. 189, 759–771 (1974)
Martin, W. R., Fraser, H. F., Gorodetzky, C. W., Rosenberg, D. E.: Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2′-hydroxy-5,9-dimethyl-6,7-benzomorphon (Cyclazocine, WIN-20, 740, ARC II-C-3(. J. Pharmacol. exp. Ther. 150, 426–436 (1965)
Martin, W. R., Gorodetzky, C. W., McClane, T. K.: An experimental study in the treatment of narcotic addicts with cyclazocine. Clin. Pharmacol. Ther. 7, 455–465 (1966)
Martin, W. R., Jasinski, D. R., Haertzen, C. A., Kay, D. C., Jones, B. E., Mansky, P. A., Carpenter, R. W.: Methadone-a reevaluation. Arch. gen. Psychiat. 28, 286–295 (1973b)
Martin, W. R., Jasinski, D. R., Mansky, P. A.: Naltrexone, an antagonist for the treatment of heroin dependence. Arch. gen. Psychiat. 28, 784–791 (1973a)
Rosecrans, J. A., Goodloe, M. H., Bennett, G. J., Hirschhorn, I. D.: Morphine as a discriminative cue: effects of amine depletors and naloxone. Europ. J. Pharmacol. 21, 252–256 (1973)
Shannon, H. E., Holtzman, S. G.: Evaluation of the discriminative effects of morphine in the rat. J. Pharmacol. exp. Ther. 198, 54–65 (1976)
Shannon, H. E., Holtzman, S. G.: Further evaluation of the discriminative effects of morphine. J. Pharmacol. exp. Ther. (in press, 1976b)
Villarreal, J. E., Karbowski, M. G.: The actions of narcotic antagonists in morphine-dependent rhesus monkeys. In: Advances in biochemical psychopharmacology, vol. 8, M. C. Braude, E. L. May, J. P. Smith, and J. E. Villarreal, eds., pp. 273–289. New York: Raven Press 1974
Winter, C. A., Flataker, L.: Studies on heptazone (6-Morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs. J. Pharmacol. exp. Ther. 98, 305–317 (1950)
Winter, J. C.: The stimulus properties of morphine and ethanol. Psychopharmacologia (Berl.) 44, 209–214 (1975)
Zaks, A., Jones, T., Fink, M., Freedman, A. M.: Naloxone treatment in opiate dependence. J. Amer. med. Ass. 215, 2108–2110 (1971)
Author information
Authors and Affiliations
Additional information
Predoctoral trainee of the Public Health Service Graduate Pharmacology Training Grant 2T1 GM179. This project represents partial fulfillment of the degree of Doctor of Philosophy at Emory University
Recipient of Research Scientist Development Award K02 DA00008
Rights and permissions
About this article
Cite this article
Shannon, H.E., Holtzman, S.G. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone. Psychopharmacology 50, 119–124 (1976). https://doi.org/10.1007/BF00430479
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00430479